ATE162532T1 - Merschliches cnp-gen und vorläufer protein - Google Patents
Merschliches cnp-gen und vorläufer proteinInfo
- Publication number
- ATE162532T1 ATE162532T1 AT91116557T AT91116557T ATE162532T1 AT E162532 T1 ATE162532 T1 AT E162532T1 AT 91116557 T AT91116557 T AT 91116557T AT 91116557 T AT91116557 T AT 91116557T AT E162532 T1 ATE162532 T1 AT E162532T1
- Authority
- AT
- Austria
- Prior art keywords
- precursor protein
- human cnp
- human
- cnp gene
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP02259698A JP3026354B2 (ja) | 1990-09-27 | 1990-09-27 | ヒトcnp遺伝子及び前駆体蛋白 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE162532T1 true ATE162532T1 (de) | 1998-02-15 |
Family
ID=17337688
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96114549T ATE388165T1 (de) | 1990-09-27 | 1991-09-27 | Menschliches cnp-gen und vorläuferprotein |
| AT91116557T ATE162532T1 (de) | 1990-09-27 | 1991-09-27 | Merschliches cnp-gen und vorläufer protein |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96114549T ATE388165T1 (de) | 1990-09-27 | 1991-09-27 | Menschliches cnp-gen und vorläuferprotein |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6034231A (de) |
| EP (2) | EP0477971B1 (de) |
| JP (1) | JP3026354B2 (de) |
| AT (2) | ATE388165T1 (de) |
| DE (2) | DE69133593T2 (de) |
| DK (1) | DK0477971T3 (de) |
| ES (2) | ES2113865T3 (de) |
| GR (1) | GR3026554T3 (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL142118A0 (en) * | 2001-03-20 | 2002-03-10 | Prochon Biotech Ltd | Method and composition for treatment of skeletal dysplasias |
| BRPI0203172B8 (pt) | 2001-09-28 | 2021-05-25 | Nakao Kazuwa | composição farmacêutica para acondroplasia |
| SG159387A1 (en) | 2002-11-26 | 2010-03-30 | Biocon Ltd In | Modified natriuretic compounds, conjugates, and uses thereof |
| ES2465141T3 (es) * | 2004-03-31 | 2014-06-05 | Kazuwa Nakao | Remedio o medicamento preventivo para la artritis |
| KR20070007842A (ko) | 2004-03-31 | 2007-01-16 | 카즈와 나카오 | 신장증가용 조성물 |
| PL1759001T3 (pl) | 2004-04-21 | 2011-09-30 | Alexion Pharma Inc | Koniugaty dostarczane do kości i sposób ich zastosowania do nakierowywania białek do kości |
| WO2006076471A2 (en) * | 2005-01-12 | 2006-07-20 | Nobex Corporation | Bnp conjugates and methods of use |
| WO2007061715A2 (en) * | 2005-11-18 | 2007-05-31 | The Brigham & Women's Hospital, Inc. | Detection, generation and uses of atherosclerosis-protective vascular endothelium |
| AR069409A1 (es) * | 2007-11-21 | 2010-01-20 | Biomarin Pharm Inc | Variantes de peptidos natriureticos de tipo c |
| PT2277890E (pt) * | 2008-05-23 | 2016-03-31 | Daiichi Sankyo Co Ltd | Péptido capaz de prolongar o semi-período de vida do péptido de interesse no plasma |
| EP2432489B1 (de) | 2009-05-20 | 2016-10-05 | BioMarin Pharmaceutical Inc. | Varianten des natriuretischen peptids typ c |
| JP6055779B2 (ja) | 2010-12-27 | 2016-12-27 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | ナトリウム利尿ペプチドを含む組成物およびその使用方法 |
| KR20140084201A (ko) | 2011-10-19 | 2014-07-04 | 알렉시온 파마 홀딩 | 알칼리성 포스파타제 및/또는 나트륨이뇨 펩티드를 포함하는 조성물 및 그의 사용 방법 |
| US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| WO2016007873A1 (en) | 2014-07-11 | 2016-01-14 | The Regents Of The University Of Michigan | Compositions and methods for treating craniosynostosis |
| JP6787894B2 (ja) | 2014-12-05 | 2020-11-18 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 組換えアルカリホスファターゼを用いた発作の処置 |
| CA2973883A1 (en) | 2015-01-28 | 2016-08-04 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
| PT3328416T (pt) | 2015-07-30 | 2024-04-10 | Biomarin Pharm Inc | Utilização de variantes do péptido natriurético de tipo c para tratar as displasias esqueléticas |
| JP6993961B2 (ja) | 2015-08-17 | 2022-01-14 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | アルカリホスファターゼの製造 |
| EP3355904A4 (de) | 2015-09-28 | 2019-06-12 | Alexion Pharmaceuticals, Inc. | Identifizierung wirksamer dosierungsschemata für gewebeunspezifische alkalische phosphatase-enzymersatztherapie von hypophosphatasie |
| EP3368062A4 (de) | 2015-10-30 | 2019-07-03 | Alexion Pharmaceuticals, Inc. | Verfahren zur behandlung von craniosynostose bei einem patienten |
| EP4710947A3 (de) | 2016-01-08 | 2026-06-17 | Ascendis Pharma Growth Disorders A/S | Cnp-agonisten mit kontrollierter freisetzung mit reduzierten nebenwirkungen |
| US11065306B2 (en) | 2016-03-08 | 2021-07-20 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in children |
| KR20180125979A (ko) | 2016-04-01 | 2018-11-26 | 알렉시온 파마슈티칼스, 인코포레이티드 | 알칼리성 포스파타아제로 근육 약화의 치료 |
| US10898549B2 (en) | 2016-04-01 | 2021-01-26 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in adolescents and adults |
| WO2017214130A1 (en) | 2016-06-06 | 2017-12-14 | Alexion Pharmaceuticals, Inc. | Metal impact on manufacturing of alkaline phosphatases |
| JP7018933B2 (ja) | 2016-08-18 | 2022-02-14 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 気管気管支軟化症の治療方法 |
| RU2768747C2 (ru) | 2016-09-29 | 2022-03-24 | Асцендис Фарма Гроус Дизордерс А/С | Комбинаторная терапия с агонистами cnp контролируемого высвобождения |
| KR20190129058A (ko) | 2017-03-31 | 2019-11-19 | 알렉시온 파마슈티칼스, 인코포레이티드 | 성인 및 청소년에서 저포스파타제증 (hpp)을 치료하는 방법 |
| WO2019190752A1 (en) | 2018-03-30 | 2019-10-03 | Alexion Pharmaceuticals, Inc. | Manufacturing of glycoproteins |
| WO2020033867A2 (en) | 2018-08-10 | 2020-02-13 | Alexion Pharmaceuticals, Inc. | Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase |
| MX2022003184A (es) | 2019-09-16 | 2022-06-23 | Biomarin Pharm Inc | Variantes del cnp y sus conjugados. |
| CA3161266A1 (en) | 2019-12-09 | 2021-06-17 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
| US12611447B2 (en) | 2020-09-04 | 2026-04-28 | Alexion Pharmaceuticals, Inc. | Methods for treating bone mineralization disorders |
| AU2022218782B2 (en) | 2021-02-12 | 2026-06-25 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
| MX2024000526A (es) | 2021-07-09 | 2024-02-02 | Biomarin Pharm Inc | Variantes del peptido natriuretico tipo c para tratar la displasia esqueletica en ni?os. |
| CA3242257A1 (en) | 2021-12-07 | 2023-06-15 | Biomarin Pharmaceutical Inc. | C-type natriuretic peptide therapy of bone-related disorders |
| KR102866559B1 (ko) | 2022-11-02 | 2025-10-02 | 노보 노르디스크 에이/에스 | Cnp 화합물 |
| WO2024254405A2 (en) | 2023-06-07 | 2024-12-12 | Biomarin Pharmaceutical Inc. | High throughput screen for genetic variants associated with short stature |
| IL328265A (en) | 2023-11-08 | 2026-07-01 | Biomarin Pharm Inc | CNP variants, conjugates and their formulations |
| WO2026030743A1 (en) | 2024-08-02 | 2026-02-05 | Biomarin Pharmaceutical Inc. | Treatment of short stature with cnp variants |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1339210C (en) * | 1988-05-31 | 1997-08-05 | John Lewicki | Recombinant techniques for production of novel natriuretic and vasodilator peptides |
-
1990
- 1990-09-27 JP JP02259698A patent/JP3026354B2/ja not_active Expired - Lifetime
-
1991
- 1991-09-26 US US07/765,830 patent/US6034231A/en not_active Expired - Lifetime
- 1991-09-27 AT AT96114549T patent/ATE388165T1/de not_active IP Right Cessation
- 1991-09-27 EP EP91116557A patent/EP0477971B1/de not_active Expired - Lifetime
- 1991-09-27 DK DK91116557T patent/DK0477971T3/da active
- 1991-09-27 ES ES91116557T patent/ES2113865T3/es not_active Expired - Lifetime
- 1991-09-27 DE DE69133593T patent/DE69133593T2/de not_active Expired - Lifetime
- 1991-09-27 ES ES96114549T patent/ES2302333T3/es not_active Expired - Lifetime
- 1991-09-27 DE DE69128754T patent/DE69128754T2/de not_active Expired - Lifetime
- 1991-09-27 EP EP96114549A patent/EP0769554B1/de not_active Expired - Lifetime
- 1991-09-27 AT AT91116557T patent/ATE162532T1/de not_active IP Right Cessation
-
1998
- 1998-04-06 GR GR980400741T patent/GR3026554T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0477971A2 (de) | 1992-04-01 |
| ATE388165T1 (de) | 2008-03-15 |
| GR3026554T3 (en) | 1998-07-31 |
| DE69128754T2 (de) | 1998-06-04 |
| EP0769554B1 (de) | 2008-03-05 |
| JP3026354B2 (ja) | 2000-03-27 |
| EP0769554A3 (de) | 1997-05-28 |
| DE69133593T2 (de) | 2009-04-02 |
| DK0477971T3 (da) | 1998-09-21 |
| EP0769554A2 (de) | 1997-04-23 |
| ES2302333T3 (es) | 2008-07-01 |
| JPH04139199A (ja) | 1992-05-13 |
| DE69128754D1 (de) | 1998-02-26 |
| EP0477971B1 (de) | 1998-01-21 |
| EP0477971A3 (en) | 1992-09-09 |
| ES2113865T3 (es) | 1998-05-16 |
| DE69133593D1 (de) | 2008-04-17 |
| US6034231A (en) | 2000-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69133593D1 (de) | Menschliches CNP-Gen und Vorläuferprotein | |
| IL131016A0 (en) | Selection of proteins using rna-protein fusions | |
| AU631681B2 (en) | Radiolabeled anticoagulant peptides | |
| DE69131699D1 (de) | Verändertes menschliches iL-6 | |
| DE3672924D1 (de) | Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen. | |
| DE69518751D1 (de) | Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend | |
| ATE182901T1 (de) | Für androgen-rezeptor-protein kodierende dna | |
| PT88425A (pt) | Dna sequences recombinant dna molecules and processes for producing soluble t4 proteins | |
| NO971875D0 (no) | Cathepsin 02 protease | |
| ES2184728T3 (es) | Proteinas de union a la fibronectina. | |
| FI962247A7 (fi) | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät | |
| FI885504A0 (fi) | Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning. | |
| ES548617A0 (es) | Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo | |
| FI90667C (fi) | Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia | |
| KR950702242A (ko) | 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins) | |
| FI863626A7 (fi) | DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä. | |
| DK38889D0 (da) | Onkogen-indkodet polypeptid med vaekstfaktoraktivitet | |
| DE69328060D1 (de) | Angiotensin-II Typ-1 Rezeptor und dessen Herstellung | |
| ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
| AU8957091A (en) | Immunoglobulin-binding proteins and recombinant dna molecules coding therefor | |
| EP0676413A3 (de) | Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung. | |
| EP0723016A3 (de) | Leukocyten-aktivierender Faktor | |
| FI885301A7 (fi) | Tekijä VIII:n puhdistuksessa käyttökelpoisia peptidejä | |
| DE59109235D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| DE59610098D1 (de) | Protein mit anti-tumorwirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |